Low-fluence photodynamic therapy in chronic central serous chorioretinopathy

Klais, 2009, Central serous chorioretinopathy, 1021 Jalkh, 1984, Retinal pigment epithelial decompensation. I. Clinical features and natural course, Ophthalmology, 91, 1544, 10.1016/S0161-6420(84)34095-7 Levine, 1989, Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography, Ophthalmology, 96, 854, 10.1016/S0161-6420(89)32810-7 Loo, 2002, Factors associated with reduced visual acuity during long-term follow-up patients with idiopathic central serous chorioretinopathy, Retina, 22, 19, 10.1097/00006982-200202000-00004 Spaide, 2003, Serous detachtment of the retina, Retina, 23, 820, 10.1097/00006982-200312000-00013 Guyer, 1994, Digital indocyanine green videoangiography of central serous chorioretinopathy, Arch Ophthalmol, 112, 1057, 10.1001/archopht.1994.01090200063023 Ficker, 1998, Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy, Br J Ophthalmol, 72, 829, 10.1136/bjo.72.11.829 Yap, 1996, The long-term outcome of central serous chorioretinopathy, Arch Ophthalmol, 114, 689, 10.1001/archopht.1996.01100130681007 Yannuzzi, 1992, Laser treatment of diffuse retinal pigment epitheliopathy, Eur J Ophthalmol, 2, 103, 10.1177/112067219200200301 Faurschou, 1977, Central serous retinopathy and presenile disciform macular degeneration, Acta Ophthalmol, 55, 515, 10.1111/j.1755-3768.1977.tb06129.x Ergun, 2004, Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy, Arch Ophthalmol, 122, 37, 10.1001/archopht.122.1.37 Ruiz-Moreno, 2010, Photodynamic therapy for chronic central serous chorioretinopathy, Acta Ophthalmol, 88, 371, 10.1111/j.1755-3768.2008.01408.x Yannuzzi, 2003, Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study, Retina, 23, 288, 10.1097/00006982-200306000-00002 Tarantola, 2008, Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy, Lasers Surg Med, 40, 671, 10.1002/lsm.20720 Berthout, 2008, Dynamic phototherapy as a treatment for central serous chorioretinopathy, J Fr Ophtalmol, 31, 751, 10.1016/S0181-5512(08)74393-6 Valmaggia, 2006, Photodynamic therapy in the treatment of chronic central serous chorioretinopathy, Klin Monbl Augenheilkd, 223, 372, 10.1055/s-2006-926567 Taban, 2004, Chronic central serous chorioretinopathy: photodynamic therapy, Am J Ophthalmol, 137, 1073, 10.1016/j.ajo.2004.01.043 Cardillo Piccolino, 2003, Photodynamic therapy for chronic central serous chorioretinopathy, Retina, 23, 752, 10.1097/00006982-200312000-00002 Chan, 2003, Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level, Br J Ophthalmol, 87, 1453, 10.1136/bjo.87.12.1453 1999, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report, Arch Ophthalmol, 117, 1329, 10.1001/archopht.117.10.1329 Lee, 2009, Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy, Jpn J Ophthalmol, 53, 52, 10.1007/s10384-008-0613-z Reche-Frutos, 2008, Photodynamic therapy in severe chronic central serous chorioretinopathy, Arch Soc Esp Oftalmol, 83, 9 Yaman, 2007, Choroidal neovascularization following photodynamic therapy in a patient with chronic central serous chorioretinopathy, Bull Soc Belge Ophtalmol, 69 Reibaldi, 2010, Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial, Am J Ophthalmol, 149, 10.1016/j.ajo.2009.08.026 Chan, 2008, Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study, Retina, 28, 85, 10.1097/IAE.0b013e318156777f Koytak, 2010, Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy, Retina, 30, 1698, 10.1097/IAE.0b013e3181da4354 Cervera, 2008, Low dose photodynamic therapy for chronic central serous chorioretinopathy, Arch Soc Esp Oftalmol, 83, 525 Chan, 2008, Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial, Ophthalmology, 115, 1756, 10.1016/j.ophtha.2008.04.014 Zhao, 2009, Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin, Retina, 29, 1155, 10.1097/IAE.0b013e3181a6c028 Henderson, 2006, Fluence rate as a modulator of PDT mechanisms, Lasers Surg Med, 38, 489, 10.1002/lsm.20327 Xu, 2005, Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy, Lasers Med Sci, 19, 257, 10.1007/s10103-005-0331-4 Framme, 2006, Comparison of reduced and standard light application in photodynamic therapy of the eye in two rabbit models, Graefes Arch Clin Exp Ophthalmol, 244, 773, 10.1007/s00417-005-0221-2 Besozzi, 2010, Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety, Graefes Arch Clin Exp Ophthalmol, 248, 497, 10.1007/s00417-009-1232-1 Reibaldi, 2009, Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy, Eur J Ophthalmol, 19, 154, 10.1177/112067210901900126